Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT05387980
A Study to Learn About the Study Medicine (CIBINQO) in People With Atopic Dermatitis.
Sponsor: Pfizer
View on ClinicalTrials.gov
Summary
The purpose of this study is to learn about the safety and effectiveness (how well the study treatment works) of the study medicine (CIBINQO) for the potential treatment of atopic dermatitis in people under Japanese medical practice.
Official title: CIBINQO® TABLETS SPECIAL INVESTIGATION
Key Details
Gender
All
Age Range
12 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1128
Start Date
2022-04-19
Completion Date
2028-11-01
Last Updated
2026-03-19
Healthy Volunteers
No
Conditions
Interventions
DRUG
CIBINQO
Patients receiving CIBINQO tablets by mouth for the treatment of Atopic Dermatitis.
Locations (1)
Pfizer Local Country Office
Tokyo, Japan